CLINICAL_TRIALS
trial_result
· 2013-11-19
Clinical Trial Update: Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure Hydrocephalus [Phase 3]
Summary
GE Healthcare sponsored a Phase 3 trial evaluating PET imaging of brain amyloid in normal pressure hydrocephalus, which has been terminated; results were posted…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: GE Healthcare | Conditions: Normal Pressure Hydrocephalus | Phase 3 | Status: TERMINATED | Results posted: 2013-11-19